NCT02571205View on ClinicalTrials.gov

Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

March 31, 2019

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

Sustanon (testosterone)

Standard incremental regimen of Sustanon

Trial Locations (1)

NE1 3BZ

Institute of Genetic Medicine, Newcastle upon Tyne

All Listed Sponsors
lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT02571205 - Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter